Empagliflozin and Dapagliflozin Reduce ROS Generation and Restore NO Bioavailability in Tumor Necrosis Factor α-Stimulated Human Coronary Arterial Endothelial Cells

Laween Uthman(Amsterdam University Medical Centers), Nina C. Weber(University of Amsterdam)
Cellular Physiology and Biochemistry
November 14, 2019
Cited by 204


Related Papers